Lo, Yi-Ching

Urgosedin inhibits hypotension, hypoglycemia, and pro-inflammatory mediators induced by lipopolysaccharide. [electronic resource] - Journal of cardiovascular pharmacology Sep 2004 - 363-71 p. digital

Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't

0160-2446

10.1097/01.fjc.0000137155.63604.7a doi


Administration, Oral
Adrenergic alpha-Antagonists--administration & dosage
Animals
Aorta, Thoracic--drug effects
Benzene Derivatives--administration & dosage
Blood Glucose
Cell Line
Cytokines--adverse effects
Dose-Response Relationship, Drug
Drug Evaluation, Preclinical--methods
Gene Expression Regulation, Enzymologic--drug effects
Heart Rate--drug effects
Hypoglycemia--chemically induced
Hypotension--chemically induced
Inflammation Mediators--antagonists & inhibitors
Injections, Intraperitoneal
Injections, Intravenous
Lipopolysaccharides--administration & dosage
Mice
Mice, Inbred ICR
Muscle Contraction--drug effects
Muscle, Smooth, Vascular--drug effects
Nitric Oxide Synthase--antagonists & inhibitors
Nitric Oxide Synthase Type II
Norepinephrine--pharmacology
Piperazines--administration & dosage
Prodrugs--adverse effects
Rats
Rats, Wistar
Serotonin--pharmacology
Serotonin Agents--administration & dosage
Toxicity Tests, Acute--methods